Publication: Fixed-duration oral targeted therapies and chronic lymphocytic leukemia in Canada
-
Learn morePublication: Venetoclax and azacitidine for acute myeloid leukemia in Canada
A study evaluating, from a Canadian perspective, the economic impact of venetoclax in combination with azacitidine for the treatment of patients with acute myeloid leukemia.…
-
Learn more
Publication: Oral targeted therapy and chronic lymphocytic leukemia in Canada
Presenting an impactful pan-Canadian collaboration in the treatment of CLL: Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
-
Learn morePublication: Network meta-analysis on latanoprostene bunod and glaucoma
A network meta-analysis by our team focusing on the treatment of glaucoma: Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular…